| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.23 | 0.1 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |